Optipharm.CO.,LTD (153710.KQ)
KOSDAQ · KRW · Healthcare · Diagnostics & Research
₩4,295 (-1.26%) as of
Key statistics
- Market cap
- 63.01B
- Dividend yield
- 0.00%
- 52-week range
- 4,075.00 – 6,250.00
- Beta
- 0.08
- Revenue (TTM)
- 23.59B
- Profit margin
- -7.89%
- Volume
- 7.66k
About Optipharm.CO.,LTD
Optipharm.CO.,LTD operates as a biomedical solution provider in South Korea. It also engages in animal disease diagnosis, animal medicine, bacteriophage, Medipig, xenogenic organs, VLP vaccines, xenotransplantation, and other optipharm products, as well as veterinary drug for feed additives and laboratory animal Medipig business. The company was formerly known as Optiparm Solution Co., Ltd. and changed its name to Optipharm.CO.,LTD in 2012. Optipharm.CO.,LTD was founded in 2000 and is based in Cheongju, South Korea.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Cheongju, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.